LUPIN
|
The Current P/E Ratio of LUPIN is 24.02.
Share Price | ₹1,957.5 | Oct 09,2025 |
Market Cap | ₹89,416.3 Cr | |
Earnings-TTM | ₹3,722.2 Cr | TTM-Consolidated Results |
Price/Earnings | 24.02x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of LUPIN
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹89,416.3 Cr] as on Oct 09,2025
(/) Earnings [ ₹3,722.2 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 24.02x ]
Thus, for LUPIN , the investors are currently willing to pay 24.02 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of LUPIN !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of LUPIN over the last five years.
Historical PE (Price/Earnings) ratio chart of LUPIN
PE Ratio Performance Analysis for LUPIN
- LUPIN 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 34.67x.
- LUPIN 's operated at median p/e ratio of 38.08x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LUPIN 's p/e ratio peaked in Mar2023 at 68.54x.
- LUPIN 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does LUPIN 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
LUPIN | 3,722.18 | 24.02 | 89,416.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 38.22 | 397,894.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 70.59 | 162,781.0 |
CIPLA LTD | 5,406.81 | 22.60 | 122,179.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 60.00 | 120,118.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.15 | 103,964.0 |
MANKIND PHARMA LTD | 1,905.51 | 53.71 | 102,348.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.61 | 100,226.0 |
AUROBINDO PHARMA LTD | 3,417.93 | 19.01 | 64,988.8 |
ABBOTT INDIA LTD | 1,452.29 | 43.43 | 63,066.3 |
ALKEM LABORATORIES LTD | 2,334.08 | 28.05 | 65,475.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs LUPIN 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.15x |
Max industry PE | 70.59x |
Median industry PE | 28.05x |
Average industry PE | 36.31x |
You may also like the below Video Courses